PE-backed Canopy Biosciences acquires Core Diagnostics

Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers.

4 December 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles